Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford study
暂无分享,去创建一个
T. Spector | G. Zhai | B. Kato | F. Williams | D. Hart | G. Livshits | Huizhong Wang
[1] M. Goldring,et al. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism , 2008, Annals of the rheumatic diseases.
[2] P. Nilsson,et al. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. , 2008, Osteoarthritis and cartilage.
[3] C. Nathan. Epidemic Inflammation: Pondering Obesity , 2008, Molecular medicine.
[4] B. Nicklas,et al. Inflammatory Biomarkers and Physical Function in Older, Obese Adults with Knee Pain and Self‐Reported Osteoarthritis After Intensive Weight‐Loss Therapy , 2008, Journal of the American Geriatrics Society.
[5] G. Zhai,et al. Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study , 2008, Osteoporosis International.
[6] T. Sculco,et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. , 2007, Osteoarthritis and cartilage.
[7] David T Felson,et al. Clinical practice. Osteoarthritis of the knee. , 2006, The New England journal of medicine.
[8] J. Katz,et al. Total joint replacement in osteoarthritis. , 2006, Best practice & research. Clinical rheumatology.
[9] Sophia Rabe-Hesketh,et al. Multilevel and Longitudinal Modeling Using Stata , 2005 .
[10] R. Yu,et al. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6 , 2005 .
[11] M. Dougados,et al. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients. , 2005, Osteoarthritis and cartilage.
[12] S. Bohlega. The Burden of Musculoskeletal Conditions at the Start of the New Millennium , 2004, World Health Organization technical report series.
[13] S. Rubin,et al. Inflammatory Markers and Incident Mobility Limitation in the Elderly , 2004, Journal of the American Geriatrics Society.
[14] Alfred L Fisher,et al. Of Worms and Women: Sarcopenia and its Role in Disability and Mortality , 2004, Journal of the American Geriatrics Society.
[15] L. Ferrucci,et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.
[16] Kwan Tat Steeve,et al. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. , 2004 .
[17] H. Brenner,et al. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein , 2004, Annals of the rheumatic diseases.
[18] J. Buckwalter,et al. The burden of musculoskeletal conditions at the start of the new millennium , 2003 .
[19] T. Spector,et al. The relationship of joint hypermobility, bone mineral density, and osteoarthritis in the general population: the Chingford Study. , 2003, The Journal of rheumatology.
[20] P. Garcia-Lorda,et al. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. , 2003, Obesity research.
[21] J. Reginster,et al. The prevalence and burden of arthritis. , 2002, Rheumatology.
[22] U. Das. Is obesity an inflammatory condition? , 2001, Nutrition.
[23] T. Spector,et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. , 1997, Arthritis and rheumatism.
[24] M. Sowers,et al. Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study. , 1994, American journal of epidemiology.
[25] C. Dinarello,et al. The role of interleukin-1 in disease. , 1993, The New England journal of medicine.
[26] J. Vilček,et al. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. , 1989, Journal of immunology.
[27] K. Tracey,et al. Peptide Regulatory Factors CACHECTIN/TUMOUR NECROSIS FACTOR , 1989, The Lancet.
[28] B. Beutler,et al. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. , 1988, Endocrine reviews.
[29] J. Kellgren,et al. Radiological Assessment of Osteo-Arthrosis , 1957, Annals of the rheumatic diseases.
[30] S. Kwan Tat,et al. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. , 2004, Cytokine & growth factor reviews.
[31] M. Yano,et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. , 1996, The Journal of clinical investigation.
[32] K. Tracey,et al. Cachectin/tumour necrosis factor. , 1989, Lancet.